The estimated Net Worth of Richard M Krasno is at least $551 Mille dollars as of 29 January 2024. Mr. Krasno owns over 30,000 units of BioCardia stock worth over $281,066 and over the last 18 years he sold BCDA stock worth over $0. In addition, he makes $269,814 as Independent Director at BioCardia.
Richard has made over 44 trades of the BioCardia stock since 2007, according to the Form 4 filled with the SEC. Most recently he bought 30,000 units of BCDA stock worth $29,700 on 29 January 2024.
The largest trade he's ever made was buying 80,000 units of BioCardia stock on 8 January 2007 worth over $104,000. On average, Richard trades about 8,672 units every 59 days since 2006. As of 29 January 2024 he still owns at least 103,333 units of BioCardia stock.
You can see the complete history of Mr. Krasno stock trades at the bottom of the page.
Dr. Richard M. Krasno Ph.D. serves as Independent Director of the Company. He was appointed to our board of directors in October 2016. Dr. Krasno has served as a director of OPKO Health, Inc. since 2017. Dr. Krasno previously served as a director on the board of Ladenburg Thalmann from 2006 until 2020 and on the board of Castle Brands, Inc. from 2014 until 2019. Dr. Krasno served as the executive director of the William R. Kenan, Jr. Charitable Trust from 1999 to 2014 and, from 1999 to 2010, as president of the four affiliated funds. Prior to that, Dr. Krasno was the president of the Monterey Institute of International Studies in Monterey, California. From 2004 to 2012, Dr. Krasno also served as a director of the University of North Carolina Health Care System and served as chairman of the board of directors from 2009 to 2012. From 1981 to 1998, he served as president and chief executive officer of the Institute of International Education in New York. He also served as Deputy Assistant Secretary of Education in Washington, D.C. from 1979 to 1980. Mr. Krasno holds a Bachelor of Science from the University of Illinois and a Ph.D. from Stanford.
As the Independent Director of BioCardia, the total compensation of Richard Krasno at BioCardia is $269,814. There are 6 executives at BioCardia getting paid more, with Peter Altman having the highest compensation of $677,501.
Richard Krasno is 78, he's been the Independent Director of BioCardia since 2016. There are 1 older and 13 younger executives at BioCardia. The oldest executive at BioCardia Inc. is Simon Stertzer, 83, who is the Independent Chairman of the Board.
Richard's mailing address filed with the SEC is 4400, Biscayne Boulevard, Buena Vista, Miami, Miami-Dade County, Florida, 33137, United States.
Over the last 8 years, insiders at BioCardia have traded over $2,555,815 worth of BioCardia stock and bought 6,474,371 units worth $6,325,055 . The most active insiders traders include Phillip Md Et Al Frost Gamm..., Simon H Stertzer e Richard M Krasno. On average, BioCardia executives and independent directors trade stock every 48 days with the average trade being worth of $1,321,186. The most recent stock trade was executed by Phillip Md Et Al Frost Gamm... on 19 January 2024, trading 129,802 units of BCDA stock currently worth $55,815.
we are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. biocardia is developing proprietary comprehensive biotherapeutic solutions for cardiovascular disease in its cardiamp™ and cardiallo™ therapies. clinical results supporting both therapeutic programs are compelling and build upon the most rigorous data in the field to date with intramyocardial delivery of marrow-derived cells. these programs are enabled by the company's helix™ transendocardial delivery systems and morph® vascular access products, which are partnered to enable other promising biotherapeutic programs.
BioCardia executives and other stock owners filed with the SEC include: